Nyirjesy, Sarah C.
Judd, Ryan T.
Alfayez, Yazen
Lancione, Peter
Swendseid, Brian
von Windheim, Natalia
Nogan, Stephen
Seim, Nolan B.
VanKoevering, Kyle K.
Article History
Received: 11 November 2022
Accepted: 31 December 2022
First Online: 23 February 2023
Declarations
:
: This device was approved via concurrence from The Ohio State University Institutional Review Board and by the United States Food and Drug Administration. Consent was obtained from the patient’s power of attorney.
: Consent was obtained by patient’s power of attorney for device placement and publication of case (available upon request).
: Kyle K. VanKoevering – Unrestricted research funding from KLS Martin, MakeMedical co-founder and partial owner.Natalia von Windheim - Shareholder in restor3d, travel and postdoc sponsored by unrestricted research funding from KLS Martin.The other authors declare that they have no competing interests.